M. Kraft, J. Corren, C. Ambrose, B. Cook, N. Clarke, G. Hunter, N. Molfino, S. Ponnarambil
{"title":"Tezepelumab与安慰剂在严重、未控制哮喘患者的圣乔治呼吸问卷评分中有临床意义的改善:来自3期NAVIGATOR研究的结果","authors":"M. Kraft, J. Corren, C. Ambrose, B. Cook, N. Clarke, G. Hunter, N. Molfino, S. Ponnarambil","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2360","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":166658,"journal":{"name":"B15. NOVEL BIOMARKERS AND USES OF THERAPEUTICS IN ASTHMA","volume":"36 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinically Meaningful Improvements in St George’s Respiratory Questionnaire Score with Tezepelumab Versus Placebo in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study\",\"authors\":\"M. Kraft, J. Corren, C. Ambrose, B. Cook, N. Clarke, G. Hunter, N. Molfino, S. Ponnarambil\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2360\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":166658,\"journal\":{\"name\":\"B15. NOVEL BIOMARKERS AND USES OF THERAPEUTICS IN ASTHMA\",\"volume\":\"36 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B15. NOVEL BIOMARKERS AND USES OF THERAPEUTICS IN ASTHMA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2360\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B15. NOVEL BIOMARKERS AND USES OF THERAPEUTICS IN ASTHMA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2360","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clinically Meaningful Improvements in St George’s Respiratory Questionnaire Score with Tezepelumab Versus Placebo in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study